Search Results 251-260 of 8506 for Terminal

  1. Rectal cancer - Survival rates - Mayo Clinic

    Learn about the symptoms, causes and prevention of this cancer that starts in the rectum. Treatments include surgery, radiation therapy and chemotherapy.

  2. Anesthesiology and Perioperative Medicine - Clinical trials

    Mayo Clinic's Department of Anesthesiology sees more than 145000 patients each year and integrates patient care, research and education, resulting in ...

  3. Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study (CHESS) - Mayo Clinic

    Life expectancy of less than 6 months due to comorbid terminal conditions. 20. Concurrent participation in another research protocol for investigation of an ...

  4. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB

  5. Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma - Mayo Clinic

    ... terminal deoxynucleotidyl transferase (TdT), CD34 or CD99 will be assessed for expression; cases with uncertain expression will receive additional review ...

  6. Research data demonstrate positive outcomes associated with novel prosthetic hand - Mayo Clinic

    Our long-term goal is to use these study findings to help us design and build a low-cost, high-performance prosthetic hand terminal device that will be ...

  7. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

    Treatment with experimental non_FDA approved therapy within 5 terminal half lives or 4 weeks prior to enrollment, whichever is longer; Other past or current ...

  8. A Study to Evaluate the Safety and Tolerability of LCZ696 Followed by a 52-week Study of LCZ696 Compared With Enalapril in Pediatric Patients with Heart Failure - Mayo Clinic

    Concurrent terminal illness or other severe disease (e.g., acute lymphocytic leukemia) or other significant laboratory values that, in the opinion of the ...

  9. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    Participation eligibility · abscess (abdominal or peri-anal); · symptomatic bowel strictures; · > 2 entire missing segments of the following 5 segments: terminal ...

  10. Expanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis With Cardiomyopathy - Mayo Clinic

    New York Heart Association (NYHA) Class IV NYHA Class III AND ATTR amyloidosis disease Stage 3 (defined as both N-terminal prohormone B-type natriuretic ...